Opioids are a high-risk medicine frequently used to manage palliative patients' cancer-related pain and other symptoms. Despite the high volume of opioid use in inpatient palliative care services, and the potential for patient harm, few studies have focused on opioid errors in this population. Objectives To (i) identify the number of opioid errors reported by inpatient palliative care services, (ii) identify reported opioid error characteristics and (iii) determine the impact of opioid errors on palliative patient outcomes. Methods A 24-month retrospective review of opioid errors reported in three inpatient palliative care services in one Australian state. results Of the 55 opioid errors identified, 84% reached the patient. Most errors involved morphine (35%) or hydromorphone (29%). Opioid administration errors accounted for 76% of reported opioid errors, largely due to omitted dose (33%) or wrong dose (24%) errors. Patients were more likely to receive a lower dose of opioid than ordered as a direct result of an opioid error (57%), with errors adversely impacting pain and/or symptom management in 42% of patients. Half (53%) of the affected patients required additional treatment and/or care as a direct consequence of the opioid error. conclusion This retrospective review has provided valuable insights into the patterns and impact of opioid errors in inpatient palliative care services. Iatrogenic harm related to opioid underdosing errors contributed to palliative patients' unrelieved pain. Better understanding the factors that contribute to opioid errors and the role of safety culture in the palliative care service context warrants further investigation. bAckgrOund Medication delivery errors pose one of the greatest risks to patient safety. 1 Several drug classes, classified as 'high-risk' medicines, are more likely to cause significant patient harm if they are prescribed or administered incorrectly. 2 Opioids are a high-risk medicine frequently prescribed and administered to palliative patients in order to manage complex pain and other symptoms. The risk of medication errors, and resultant patient harm(s), is increased in palliative patients who tend to be older, have multiple comorbidities and are taking numerous medications. 3 Palliative care clinicians have identified that safe opioid use is a patient safety priority. 4 Despite the high volume of opioid use in palliative care services, few studies have reported on medication safety events causing patient harm in this population.
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AiM
To (i) identify the number of opioid errors reported by specialist palliative care inpatient services, (ii) identify reported opioid error characteristics and (iii) determine the impact of opioid errors on palliative patient outcomes. Services 1 and 3 used paper medication charts to record opioid orders and administrations, service 2 used an electronic medication management system. Services 2 and 3 employed full-time clinical pharmacists.
inclusion criteria
Errors involving: a Schedule 8 opioid ('opioid'); reported via the services' internal incident management system; Short report and an inpatient aged ≥18 years, admitted to the palliative care service during the review period.
incident reporting systems
At the time of this review, mandated incident reporting was undertaken using one of two electronic incident management/reporting systems in NSW ('State').
Opioid management
All palliative care services in NSW are required to adhere to the State-mandated incident management, medication handling and high-risk medicine management policies. 6 The opioid delivery process is required to be witnessed by another person, with an independent double check prior to administration (online supplementary textbox 1).
data collection
A custom data collection tool was developed and piloted to capture reported opioid errors. An error was defined as 'any unplanned event which causes, or has the potential to cause, harm to a patient' and includes errors that are intercepted before causing patient harm ('near miss').
data analysis
Detailed descriptive statistics and percentage analysis was used to quantify and characterise opioid errors. Quantitative data analysis was undertaken with the IBM SPSS Statistics V.25 software package. The National Coordinating Council for Medication Error Reporting and Prevention Taxonomy  8 and Index   9 were used to guide categorisation of opioid incidents according to incident type and patient outcome.
results
Opioid error characteristics
Opioid errors accounted for 32% (n=55) of all reported medication errors (n=174), equating to 0.9 (±1.5) opioid errors per 1000 occupied bed days (service 1: 1.0; service 2: 0.6; service 3: 1.7) (online supplementary figure 1). Eighty-four per cent (n=46) of reported opioid errors reached the patient. The mean age of the affected patients was 71.3 years (±10.7). Most patients (84%, n=46) had cancer and almost two-thirds (62%, n=54) of patients died during this admission. The mean length of stay for these patients was 27.2 days (±20.0) (online supplementary table 1).
Two-thirds of reported opioid errors involved morphine (35%, n=19) or hydromorphone (29%, n=16). Opioid errors were more likely to occur with regular (78%, n=43) than as required ('PRN') orders (27%, n=10) and occurred more frequently with oral (49%, n=27) than subcutaneous (36%, n=20) or transdermal opioid administration (15%, n=8). The peak time for opioid errors was between 08:00 and 08:59 hours (20%, n=10).
reported opioid error types Administration errors
Opioid administration errors accounted for three-quarters (76%, n=42) of reported opioid errors and were the most frequently reported opioid error type at each service (online supplementary table 2). Omitted opioid doses (33%, n=14) were the leading administration error reported. All omitted doses were non-therapeutic omissions rather than doses withheld based on clinical judgement. Wrong dose errors (24%, n=10) occurred primarily with oral opioids (82%, n=9) (table 1). One-fifth (19%, n=8) of administration errors occurred due to missing transdermal patch errors (n=4) or non-removal of original transdermal patch (n=4) (table 1).
Prescribing and other errors
Opioid-prescribing errors comprised 15% (n=8) of reported opioid errors and were most frequently reported with regular hydromorphone (63%, n=5). Prescribing errors were primarily due to medication charting errors (50%, n=4), opioid conversion (25%, n=2) or wrong drug errors (25%, n=2). A very small number of 'near miss' (wrong patient) (5%, n=3) and dispensing errors (4%, n=2) were reported (online supplementary table 2).
Patient impact
One-third (33%, n=18) of opioid errors resulted in patient harm (online supplementary table 3), requiring clinical intervention as a direct consequence of the error. An additional one-fifth (20%, n=11) of patients required monitoring and/or a clinical intervention to preclude harm following an opioid error.
Over half of patients (57%, n=26) received a lower dose of opioid than ordered ('underdose') as a direct consequence of an error, with 42% (n=11) of these patients requiring PRN opioids to manage their increased pain (n=9) or shortness of breath (n=2) immediately following the error.
Thirty-nine per cent (n=18) of patients experienced an opioid overdose due to the opioid error, ranging from 1.5-fold to 11-fold higher doses of the intended opioid order being administered (table 1). Opioid toxicity was documented in 39% (n=7) of these patients; however, administration of an opioid reversal agent was not required.
discussiOn
The percentage of reported medication errors involving opioids in this review is almost threefold higher than that previously reported in other healthcare settings. 10 11 Comparatively, opioid errors comprised up to 12% of all reported medication errors in acute care 10 and nursing homes 11 internationally. These differences may reflect the higher volume of opioids used in palliative care inpatient services compared with other healthcare settings.
Short report
The differences in opioid error reporting noted in this review may be linked to the use of electronic medication management systems versus paperbased systems as the lowest overall incidence of both reported opioid errors and omitted dose errors came from the service using the electronic system. In contrast, omitted doses comprised up to two-thirds of reported administration errors in the two services using paper medication charts. Electronic medication management systems have been shown to reduce medication errors in other clinical settings, 12 which may account for the differences observed in this review; however, further investigation is warranted to confirm this observation. 
Another difference between the services was the proportionally greater number of prescribing errors reported by the service without an on-site clinical pharmacist. The presence of an on-site pharmacist may help identify and avert opioid prescribing errors before they are administered, 13 and this factor warrants further exploration in the palliative care service context.
Over half of palliative inpatients in this review required clinical intervention and/or monitoring to preclude or manage iatrogenic harm(s) as a direct consequence of an opioid error. The majority of opioid errors in this review resulted in opioid underdosing, which is over double the rate reported in other hospital settings (57% vs 23%), where opioid overdose is a more likely error outcome.
14 Although wrong drug and wrong dose administration errors caused opioid underdosing in this review, omitted opioid doses were the primary contributor to opioid underdosing and subsequent adverse impact on patients' previously well-managed pain.
Unrelieved pain is a major issue in specialist palliative care, 15 and it appears opioid errors, particularly omitted dose errors, may be contributing to the burden of palliative patients' pain. Better understanding the factors that contribute to or mitigate opioid errors, including systems factors and the impact of error reporting culture, and developing strategies to prevent iatrogenic pain occurring as a result of opioid errors, is a priority for this clinical setting and population.
strengths and limitations
A major strength of this review is that it examined reported opioid errors across three similar inpatient palliative care services, identified opioid error incidence and characterised reported opioid errors in accordance with accepted taxonomies. 8 9 A limitation of this review is that, as medication errors are consistently under-reported, it is conceivable that that the actual number of medication errors patients experienced during their admission may have been higher than those reported. 16 The variations in opioid error reporting practices noted between services may reflect differences in service systems and/or error reporting cultures across services; however, this could not be confirmed by this review alone.
cOnclusiOns Establishing a baseline profile of opioid error characteristics and incidence in palliative care inpatient services is an important first step to quantifying the burden of this problem. Like most errors, opioid errors in this specialist setting occur as a result of a complex interplay of systems, health professional and patient factors. Better understanding these factors and their role in opioid errors is required. Given the variations in reporting practices between services in this review, further exploration of service characteristics and error reporting culture is also warranted.
